Feb 28, 2022

Public workspaceHuBMAP | GE/URMC/SCH Cell DIVE™ Modality Overview

  • 1University of Rochester Medical Center;
  • 2Seattle Children's Hospital;
  • 3GE Research;
  • 4University of Rochester
Icon indicating open access to content
QR code linking to this content
Protocol CitationGloria S Pryhuber, gail.deutsch, Christine Surrette, Lisa Lowery, Heidie Huyck, Cory Poole 2022. HuBMAP | GE/URMC/SCH Cell DIVE™ Modality Overview. protocols.io https://dx.doi.org/10.17504/protocols.io.b4kgqutw
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it’s working
Created: February 02, 2022
Last Modified: February 28, 2022
Protocol Integer ID: 57704
Abstract
This is an overview of all protocols currently in use for the GE/URMC/SCH Cell DIVE collaboration for the Human BioMolecular Atlas Program (HuBMAP). It includes links to each of the individual protocols that make up this project workflow.
Characterize antibodies (primary/secondary, direct conjugates, and zenon labelled antibodies) and determine any antigen effects from the Cell DIVE dye inactivation process.


Perform Cell DIVE™ multiplexed data acquisition on the final cohort.

Note
Staining is done using the Leica Bond MAX and images are acquired on the IN Cell Analyzer 2200.